Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Calgary

$17,500.00

The effect of smoking as a modifiable risk factor of secondary progression in multiple sclerosis

FY 2014-15

Summary
Multiple Sclerosis (MS) is an inflammatory and degenerative disease of the brain and spinal cord with an unknown cause. MS is the most common cause of non-traumatic neurological disability in young adults and is a common disease in Canada. It affects about one in 400 individuals in Canada, with Alberta having one of the highest rates nationwide. Most persons with MS have what is known as relapsing-remitting MS (RRMS). This disease course is characterized by repetitive periods of neurological symptoms known as a relapse, after which symptoms usually decline completely or in part (remission). Over the course of time, RRMS patients are at risk of transitioning into a form of the disease known as secondary progressive MS (SPMS). approximately 80% of RRMS patients will go on to develop SPMS, which is a more serious form of the disease. SPMS is characterized by a steady worsening of symptoms and function, without any relapses. It is currently not well known why persons with RRMS develop SPMS and if particular risk factors have anything to do with this change in disease course. In this study we will look into risk factors associated with developing SPMS. We are trying to find out which factors are linked to the risk of developing SPMS. In addition to some previously identified risk factors, we will also investigate a new factor, smoking. Investigating risk factors will help us understand what makes patients develop SPMS, and why some patients are more likely to develop SPMS than others. We're hoping that through this line of research we will be able to prevent the onset of SPMS in patients with RRMS and that this will lead to health care access to smoke cessation programs that will improve the overall quality of life and functioning of people with MS.
Program
Master's Award: Canada Graduate Scholarships
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
331300
Name
Javizian Omid
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The effect of smoking as a modifiable risk factor of secondary progression in multiple sclerosis
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Disability; Disease Outcomes; Edss; Epidemiology; Multiple Sclerosis; Natural History; Prognosis; Risk Factors; Secondary Progression; Smoking
Abstract
Multiple Sclerosis (MS) is an inflammatory and degenerative disease of the brain and spinal cord with an unknown cause. MS is the most common cause of non-traumatic neurological disability in young adults and is a common disease in Canada. It affects about one in 400 individuals in Canada, with Alberta having one of the highest rates nationwide. Most persons with MS have what is known as relapsing-remitting MS (RRMS). This disease course is characterized by repetitive periods of neurological symptoms known as a relapse, after which symptoms usually decline completely or in part (remission). Over the course of time, RRMS patients are at risk of transitioning into a form of the disease known as secondary progressive MS (SPMS). approximately 80% of RRMS patients will go on to develop SPMS, which is a more serious form of the disease. SPMS is characterized by a steady worsening of symptoms and function, without any relapses. It is currently not well known why persons with RRMS develop SPMS and if particular risk factors have anything to do with this change in disease course. In this study we will look into risk factors associated with developing SPMS. We are trying to find out which factors are linked to the risk of developing SPMS. In addition to some previously identified risk factors, we will also investigate a new factor, smoking. Investigating risk factors will help us understand what makes patients develop SPMS, and why some patients are more likely to develop SPMS than others. We're hoping that through this line of research we will be able to prevent the onset of SPMS in patients with RRMS and that this will lead to health care access to smoke cessation programs that will improve the overall quality of life and functioning of people with MS.
Competitiondate
201412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Javizian, Omid
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~